JPS6456620A - Production of hemorrhagic fever with renal syndrome virus antigen and vaccine and diagnostic agent using said antigen - Google Patents
Production of hemorrhagic fever with renal syndrome virus antigen and vaccine and diagnostic agent using said antigenInfo
- Publication number
- JPS6456620A JPS6456620A JP62213410A JP21341087A JPS6456620A JP S6456620 A JPS6456620 A JP S6456620A JP 62213410 A JP62213410 A JP 62213410A JP 21341087 A JP21341087 A JP 21341087A JP S6456620 A JPS6456620 A JP S6456620A
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- virus
- mouse
- brain
- hfrsv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PURPOSE:To obtain a hemorrhagic fever with renal syndrome virus (HFRSV) antigen, having high phylactic effects and wide antigenic spectrum, by cultivating an acclimated strain of a mouse cerebral cell of the HFRS virus in a mouse brain. CONSTITUTION:HFRSV is subcultured in mouse brains for >=10 passages and acclimated in mouse cerebral cells and the resultant acclimated strain is then cultivated in a mouse brain to collect the above-mentioned mouse brain. A solution containing a virus stabilizer (e.g., enzymic inhibitor, such as chelating agent or basic amino acid) is then added to the brain and the brain is crushed and suspended to prepare a cerebral emulsion in 5-30wt.% concentration. The resultant emulsion is subsequently centrifuged to collect a supernatant and a solution of a viral inactivator (e.g., aldehyde) is added to the supernatant to inactivate the virus and purify a virus antigen. Thereby the aimed HFRSV antigen is obtained. An HFRS vaccine and HFRS diagnostic agent are prepared by using the above-mentioned antigen.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62213410A JP2681063B2 (en) | 1987-08-26 | 1987-08-26 | Method for producing renal symptomatic hemorrhagic fever virus antigen, vaccine containing the antigen, and diagnostic agent for renal symptomatic hemorrhagic fever |
KR1019880010897A KR900007262B1 (en) | 1987-08-26 | 1988-08-26 | Production of hemorr |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62213410A JP2681063B2 (en) | 1987-08-26 | 1987-08-26 | Method for producing renal symptomatic hemorrhagic fever virus antigen, vaccine containing the antigen, and diagnostic agent for renal symptomatic hemorrhagic fever |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6456620A true JPS6456620A (en) | 1989-03-03 |
JP2681063B2 JP2681063B2 (en) | 1997-11-19 |
Family
ID=16638767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62213410A Expired - Lifetime JP2681063B2 (en) | 1987-08-26 | 1987-08-26 | Method for producing renal symptomatic hemorrhagic fever virus antigen, vaccine containing the antigen, and diagnostic agent for renal symptomatic hemorrhagic fever |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2681063B2 (en) |
KR (1) | KR900007262B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02297064A (en) * | 1989-04-26 | 1990-12-07 | Ki Koo | Reagent for diagnosing nephrotic hemorrhagic fever |
CN1059836C (en) * | 1994-09-21 | 2000-12-27 | 卫生部长春生物制品研究所 | Production of inactivated vaccine for epidemic hemorrhagic fever using primary cells of kidney of golden yellow hamster |
CN1112934C (en) * | 1999-06-23 | 2003-07-02 | 中国疾病预防控制中心病毒病预防控制所 | Epidemic hemorrhagic fever passage cell polyvalent purified vaccine |
US8463110B2 (en) | 1997-12-23 | 2013-06-11 | Intel Corporation | Storage of video stream multiplexed with random access playback after variable time delay |
JP2013527759A (en) * | 2010-05-07 | 2013-07-04 | ドイッチェス・クレープスフォルシュングスツェントルム | Modified rodent parvovirus that can grow and propagate through human glioma |
-
1987
- 1987-08-26 JP JP62213410A patent/JP2681063B2/en not_active Expired - Lifetime
-
1988
- 1988-08-26 KR KR1019880010897A patent/KR900007262B1/en active Pre-grant Review Request
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02297064A (en) * | 1989-04-26 | 1990-12-07 | Ki Koo | Reagent for diagnosing nephrotic hemorrhagic fever |
CN1059836C (en) * | 1994-09-21 | 2000-12-27 | 卫生部长春生物制品研究所 | Production of inactivated vaccine for epidemic hemorrhagic fever using primary cells of kidney of golden yellow hamster |
US8463110B2 (en) | 1997-12-23 | 2013-06-11 | Intel Corporation | Storage of video stream multiplexed with random access playback after variable time delay |
CN1112934C (en) * | 1999-06-23 | 2003-07-02 | 中国疾病预防控制中心病毒病预防控制所 | Epidemic hemorrhagic fever passage cell polyvalent purified vaccine |
JP2013527759A (en) * | 2010-05-07 | 2013-07-04 | ドイッチェス・クレープスフォルシュングスツェントルム | Modified rodent parvovirus that can grow and propagate through human glioma |
Also Published As
Publication number | Publication date |
---|---|
KR900007262B1 (en) | 1990-10-06 |
KR890003406A (en) | 1989-04-14 |
JP2681063B2 (en) | 1997-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0938467T3 (en) | Process for preparing optically pure isomers of formoterol | |
DK617386D0 (en) | METHOD OF PREPARING 2-KETO-D-GLUCARIC ACID | |
GB1522006A (en) | Feline calicivirus vaccine and a process for the production thereof | |
ATE16406T1 (en) | PROCESS FOR THE PRODUCTION OF ISOMALTULOSE (6-O-ALPHA-D-GLUCO-PYRANOSIDO-D-FRUCTOSE) USING IMMOBILIZED BACTERIAL CELLS. | |
JPS6456620A (en) | Production of hemorrhagic fever with renal syndrome virus antigen and vaccine and diagnostic agent using said antigen | |
JPS5569595A (en) | Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation | |
JPS5675097A (en) | Thermophilic aspartase and its preparation | |
ATE17954T1 (en) | MUTASTEIN, PHYSIOLOGICALLY ACTIVE SUBSTANCE AND PROCESS OF PRODUCTION. | |
Guroff et al. | Uridine phosphorylase from rat brain: characteristics and developmental course | |
Dowdle et al. | Non-specific hemadsorption by rhesus monkey kidney cells | |
JPS6434925A (en) | Method for cultivating bordetella pertussis, pertussis toxoid and mixed vaccine thereof | |
BR9407182A (en) | Immunogenic composition process of preparing non-immunopotentiating composition immunogenic process for determining the presence of antibodies kit for diagnosis to determine the presence of purified inactivated human respiratory syncytial virus and antibodies | |
Labzoffsky et al. | Isolation of a haemadsorption virus from the recent outbreak of respiratory illness in Ontario | |
ES385968A1 (en) | Highly attenuated newcastle disease virus vaccine and production thereof | |
JPS5273826A (en) | Preparation of organosilanes | |
SE8006764L (en) | PREPARATION OF 2,5-DICETOGLUCONIC ACID | |
Tobita et al. | Isolation of a novel type of interfering influenza B virus defective in the function of M gene | |
Schultz et al. | Studies on the Nature of the Viricidal Antibodies in Anti-Poliomyelitis Serum. | |
JPS54107511A (en) | Preparation of bio-active substance | |
JPS5275580A (en) | Process for the preparation of feed | |
ATE48948T1 (en) | STRAINS OF BOVINE DIRRHOEE VIRUS, THEIR PRODUCTION AND VACCINE CONTAINING THEM. | |
JPS5352682A (en) | Purification of l-methionase | |
JPS52134094A (en) | Preparation of pseudo-oxynicotine | |
NAKAGAWA et al. | STUDIES ON THE PROPAGATION OF THE FA STRAIN OF MOUSE ENCEPHALOMYELITIS VIRUS IN SUSPENDED CELL CULTURE | |
JPS5337680A (en) | Preparation of 1,3-dihydro-2h-azepin-2-ones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080808 Year of fee payment: 11 |